KOBAYASHI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,543 JPY | -0.66% |
|
+0.71% | -18.37% |
| Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
| Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Sector
Personal Products
Calendar
2024-05-09
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
5,543
JPY
Average target price
8,182
JPY
Spread / Average Target
+47.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.37% | 2.61B | |
| +9.64% | 381B | |
| +8.05% | 129B | |
| -16.39% | 62.59B | |
| +0.09% | 52.86B | |
| -12.35% | 36.11B | |
| +3.17% | 33.57B | |
| +9.80% | 17.29B | |
| +7.68% | 14.75B | |
| -9.06% | 10.82B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Kobayashi Pharmaceutical Recalls 'Beni-Koji' Supplement Following Report of Death, Kidney Damage
